BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 17630119)

  • 61. Cross-talk between glucocorticoid receptor and AP-1.
    Herrlich P
    Oncogene; 2001 Apr; 20(19):2465-75. PubMed ID: 11402341
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy.
    Hapgood JP; Avenant C; Moliki JM
    Pharmacol Ther; 2016 Sep; 165():93-113. PubMed ID: 27288728
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Glucocorticoids and the non-steroidal selective glucocorticoid receptor modulator, compound A, differentially affect colon cancer-derived myofibroblasts.
    Drebert Z; Bracke M; Beck IM
    J Steroid Biochem Mol Biol; 2015 May; 149():92-105. PubMed ID: 25666906
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacology of glucocorticoids in rheumatoid arthritis.
    Spies CM; Bijlsma JW; Burmester GR; Buttgereit F
    Curr Opin Pharmacol; 2010 Jun; 10(3):302-7. PubMed ID: 20202903
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Glucocorticoids and their receptor: mechanisms of action and clinical implications].
    Roumestan C; Gougat C; Jaffuel D; Mathieu M
    Rev Med Interne; 2004 Sep; 25(9):636-47. PubMed ID: 15363619
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mechanisms generating diversity in glucocorticoid receptor signaling.
    Revollo JR; Cidlowski JA
    Ann N Y Acad Sci; 2009 Oct; 1179():167-78. PubMed ID: 19906239
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Post-transcriptional and nongenomic effects of glucocorticoids.
    Stellato C
    Proc Am Thorac Soc; 2004; 1(3):255-63. PubMed ID: 16113443
    [TBL] [Abstract][Full Text] [Related]  

  • 68. SEGRAs: a novel class of anti-inflammatory compounds.
    Schäcke H; Hennekes H; Schottelius A; Jaroch S; Lehmann M; Schmees N; Rehwinkel H; Asadullah K
    Ernst Schering Res Found Workshop; 2002; (40):357-71. PubMed ID: 12355726
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The negative effect of dexamethasone on calcium-processing gene expressions is associated with a glucocorticoid-induced calcium-absorbing disorder.
    Kim MH; Lee GS; Jung EM; Choi KC; Jeung EB
    Life Sci; 2009 Jul; 85(3-4):146-52. PubMed ID: 19490920
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evolution of glucocorticoid receptors with different glucocorticoid sensitivity.
    Stolte EH; van Kemenade BM; Savelkoul HF; Flik G
    J Endocrinol; 2006 Jul; 190(1):17-28. PubMed ID: 16837607
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Crosstalk between TNF and glucocorticoid receptor signaling pathways.
    Van Bogaert T; De Bosscher K; Libert C
    Cytokine Growth Factor Rev; 2010 Aug; 21(4):275-86. PubMed ID: 20456998
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Changes of glucocorticoid receptor expression in the nasal polyps of patients with chronic sinusitis following treatment with glucocorticoid.
    Watanabe S; Suzaki H
    In Vivo; 2008; 22(1):37-42. PubMed ID: 18396779
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The zebrafish as a model system for glucocorticoid receptor research.
    Schaaf MJ; Chatzopoulou A; Spaink HP
    Comp Biochem Physiol A Mol Integr Physiol; 2009 May; 153(1):75-82. PubMed ID: 19168143
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Optimized glucocorticoid therapy: teaching old drugs new tricks.
    Strehl C; Buttgereit F
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):32-40. PubMed ID: 23403055
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mechanism of glucocorticoid action.
    Gower WR
    J Fla Med Assoc; 1993 Oct; 80(10):697-700. PubMed ID: 8270904
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recent advances in the development of novel glucocorticoid receptor modulators.
    Berlin M
    Expert Opin Ther Pat; 2010 Jul; 20(7):855-73. PubMed ID: 20553093
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nuclear receptor drug discovery.
    Chen T
    Curr Opin Chem Biol; 2008 Aug; 12(4):418-26. PubMed ID: 18662801
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dissociated nonsteroidal glucocorticoid receptor modulators; discovery of the agonist trigger in a tetrahydronaphthalene-benzoxazine series.
    Barker M; Clackers M; Copley R; Demaine DA; Humphreys D; Inglis GG; Johnston MJ; Jones HT; Haase MV; House D; Loiseau R; Nisbet L; Pacquet F; Skone PA; Shanahan SE; Tape D; Vinader VM; Washington M; Uings I; Upton R; McLay IM; Macdonald SJ
    J Med Chem; 2006 Jul; 49(14):4216-31. PubMed ID: 16821781
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacological characterization of intracellular, membrane, and plasma binding sites for corticosterone in house sparrows.
    Breuner CW; Orchinik M
    Gen Comp Endocrinol; 2009 Sep; 163(1-2):214-24. PubMed ID: 19236873
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [New glucocorticoids are more selective. Current knowledge can eliminate serious adverse effects].
    Nilsson S; Gustafsson JA
    Lakartidningen; 1997 Jun; 94(26-27):2465-71. PubMed ID: 9235445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.